Abstract

3563Background: The PI3K / AKT pathway has several roles in CRC growth and progression through downstream targets including the MAPK pathway. Based on strong preclinical mCRC and non-mCRC clinical ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer
Liya Liu ... Aling Shen
Cancer cell international | VOL. 21
Liya Liu, et. al.Liya Liu ... Aling Shen
18 Oct 2021
Correlation of cholesteryl ester metabolism to pathogenesis, progression and disparities in colorectal Cancer
Zhirong Liu ... Veena Shenoy
Lipids in Health and Disease | VOL. 21
Zhirong Liu, et. al.Zhirong Liu ... Veena Shenoy
16 Feb 2022
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
Qing-Bai She ... Neal Rosen
Cancer Cell | VOL. 18
Qing-Bai She, et. al.Qing-Bai She ... Neal Rosen
01 Jul 2010
Grape Seed Extract Efficacy against Azoxymethane-Induced Colon Tumorigenesis in A/J Mice: Interlinking miRNA with Cytokine Signaling and Inflammation
Molly M Derry ... Kendra M Huber
Cancer prevention research (Philadelphia, Pa.) | VOL. 6
Molly M Derry, et. al.Molly M Derry ... Kendra M Huber
01 Jul 2013
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Erratum: Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).
-
Journal of Clinical Oncology | VOL. -
--
03 Jul 2024
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial.
Sabashini K Ramchand ... Mathis Grossmann
Journal of Clinical Oncology | VOL. -
Sabashini K Ramchand, et. al.Sabashini K Ramchand ... Mathis Grossmann
02 Jul 2024
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.
Andrea B Apolo ... Amir Mortazavi
Journal of Clinical Oncology | VOL. -
Andrea B Apolo, et. al.Andrea B Apolo ... Amir Mortazavi
02 Jul 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Paul A Meyers ... Joseph A Ludwig
Journal of Clinical Oncology | VOL. -
Paul A Meyers, et. al.Paul A Meyers ... Joseph A Ludwig
02 Jul 2024
View more papers